![Matthew Cabrey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Cabrey
Directeur/Membre du Conseil chez Select Greater Philadelphia
Postes actifs de Matthew Cabrey
Sociétés | Poste | Début | Fin |
---|---|---|---|
Select Greater Philadelphia | Directeur/Membre du Conseil | 01/09/2014 | - |
Historique de carrière de Matthew Cabrey
Anciens postes connus de Matthew Cabrey
Sociétés | Poste | Début | Fin |
---|---|---|---|
Shire Plc /Old/
![]() Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Public Communications Contact | - | 23/05/2008 |
Statistiques
Internationale
Royaume-Uni | 2 |
Etats-Unis | 2 |
Opérationnelle
Public Communications Contact | 1 |
Director/Board Member | 1 |
Sectorielle
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Shire Plc /Old/
![]() Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Select Greater Philadelphia |
- Bourse
- Insiders
- Matthew Cabrey
- Expérience